RPL39P26

Across TCGA patient cohorts, RPL39P26 RNA expression is significantly associated with the go_rna of many other GO terms, with 5,726 significant associations in total. STAD shows the largest number of these associations.

The most reproducible RPL39P26-associated GO terms across cancer lineages are Peptidyl-lysine modification, Protein acylation, and Positive regulation of post-translational protein modification. Each is linked with RPL39P26 in more than 13 cancer types. Because this analysis shows association rather than direction, both RPL39P26-to-partner and partner-to-RPL39P26 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Peptidyl-lysine modification grouped by RPL39P26-low versus RPL39P26-high in UCEC.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL39P26→partner) and Y-score (partner→RPL39P26) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	Peptidyl-lysine modification →	+0.042	+0.129	<.001	<.001	3	14
ESCA	Protein acylation →	+0.042	+0.313	<.001	<.001	3	14
STAD	Positive regulation of post-translational protein modification →	+0.038	+0.273	<.001	<.001	3	14
UCEC	Endosomal transport →	+0.043	+0.232	<.001	.001	3	13
STAD	Protein polyubiquitination →	+0.039	+0.298	<.001	<.001	3	13
STAD	Regulation of microtubule-based process →	+0.028	+0.271	.001	<.001	3	13

Each partner links to its Q-omics profile. Showing the 6 strongest of 5,726 associations by consensus.

Peptidyl-lysine modification by RPL39P26 expression — UCEC

Explore this box plot interactively →